Pdt Partners, LLC Agenus Inc Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $970,242 - $1.43 Million	-412,869 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $169,269 - $332,742	57,969 Added 16.33%	412,869 $1.33 Million
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $460,500 - $613,076	92,470 Added 35.24%	354,900 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $22,604 - $48,476	8,830 Added 3.48%	262,430 $1.44 Million
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $755,728 - $1.32 Million	253,600 New	253,600 $1.01 Million

Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $40,573 - $92,769	-21,132 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.41 - $4.4 $50,928 - $92,980	21,132 New	21,132 $86,000

128

205M

1.18M

69.8K

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.74B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.